Potential role of coagulase-negative Staphylococcus infection in preterm brain injury

Advances in Neuroimmune Biology

Volumn 3, Issue 1, 2012, Pages 41-48

  Wang, Xiaoyang ^a,b   Mallard, Carina ^a   Levy, Ofer ^c,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ZHENGZHOU UNIVERSITY   (China)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cerebral palsy; inflammation; neonate; Newborn; white matter

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

BRAIN INJURY; CEREBRAL PALSY; COAGULASE NEGATIVE STAPHYLOCOCCUS; COAGULASE NEGATIVE STAPHYLOCOCCUS INFECTION; DISEASE MODEL; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; MORBIDITY; MORTALITY; NEUROPROTECTION; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SAPROPHYTICUS; WHITE MATTER INJURY;

EID: 84861985030     PISSN: 1878948X     EISSN: 18789498     Source Type: Journal    
DOI: 10.3233/NIB-2012-012034     Document Type: Review

References (97)

1. Costa SF, Miceli MH, Anaissie EJ. Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? Lancet Infect Dis. 2004; 4: 278-286. (Pubitemid 38561225)
2. Otto M. Staphylococcus epidermidis - the 'accidental'pathogen. Nat Rev Microbiol. 2009; 7: 555-567.
3. Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med. 2009; 15: 1377-1382.
4. Strunk T, Power Coombs MR, Currie AJ, Richmond P, Golenbock DT, et al. TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. PLoS ONE. 2010; 5: e10111.
5. Bansal S, Jain A, Agarwal J, Malik GK. Significance of coagulase negative staphylococci in neonates with late onset septicemia. Indian J Pathol Microbiol. 2004; 47: 586-588.
6. Isaacs D. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed. 2003; 88: F89-F93. (Pubitemid 36269526)
7. Cheung GY, Otto M. Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children. Curr Opin Infect Dis. 2010; 23: 208-216.
8. Johnson-Robbins LA, el-Mohandes AE, Simmens SJ, Keiser JF. Staphylococcus epidermidis sepsis in the intensive care nursery: a characterization of risk associations in infants <1,000 g. Biol Neonate. 1996; 69: 249-256. (Pubitemid 26145614)
9. Maas A, Flament P, Pardou A, Deplano A, Dramaix M, et al. Central venous catheter-related bacteraemia in critically ill neonates: risk factors and impact of a prevention programme. J Hosp Infect. 1998; 40: 211-224. (Pubitemid 28502305)
10. Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002; 4: 481-489. (Pubitemid 34270685)
11. Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol. 2003; 27: 293-301. (Pubitemid 37099810)
12. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis. 2002; 2: 677-685. (Pubitemid 35265063)
13. Klingenberg C, Aarag E, Ronnestad A, Sollid JE, Abrahamsen TG, et al. Coagulase-negative staphylococcal sepsis in neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response. Pediatr Infect Dis J. 2005; 24: 817-822. (Pubitemid 41324891)
14. Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol. 2008; 322: 207-228.
15. Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, et al. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology. 2007; 153: 2083-2092. (Pubitemid 47074063)
16. Sutherland IW. The biofilm matrix-an immobilized but dynamic microbial environment. Trends Microbiol. 2001; 9: 222-227. (Pubitemid 32402231)
17. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284: 1318-1322. (Pubitemid 29289651)
18. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004; 2: 95-108. (Pubitemid 39490064)
19. Monzon M, Oteiza C, Leiva J, Lamata M, Amorena B. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis. 2002; 44: 319-324. (Pubitemid 36120708)
20. Nishimura S, Tsurumoto T, Yonekura A, Adachi K, Shindo H. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci. 2006; 11: 46-50. (Pubitemid 43155856)
21. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007; 7: 379-390. (Pubitemid 46674489)
22. Schultz C, Temming P, Bucsky P, Gopel W, Strunk T, et al. Immature anti-inflammatory response in neonates. Clin Exp Immunol. 2004; 135: 130-136. (Pubitemid 38067937)
23. Harris MC, Costarino AT Jr, Sullivan JS, Dulkerian S, McCawley L, et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr. 1994; 124: 105-111. (Pubitemid 24027297)
24. PrabhuDas M, Adkins B, Gans H, King C, Levy O, et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol. 2011; 12: 189-194.
25. Patel S, Dammann O, Martin CR, Allred EN, Leviton A. Presumed and definite bacteremia in extremely low gestational age newborns. Acta Paediatr. 2011; 100: 36-41.
26. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002; 110: 285-291. (Pubitemid 34833012)
27. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth- weight infants. N Engl J Med. 2002; 347: 240-247. (Pubitemid 34787630)
28. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics. 2005; 116: 595-602. (Pubitemid 44336674)
29. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey. Clin Infect Dis. 2005; 40: 218-224. (Pubitemid 40110664)
30. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis. 2004; 39: 1460-1466. (Pubitemid 39518209)
31. Shah DK, Doyle LW, Anderson PJ, Bear M, Daley AJ, et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr. 2008; 153: 170-175, 175 e171.
32. Lopez Sastre JB, Coto Cotallo D, Fernandez Colomer B. Neonatal sepsis of nosocomial origin: an epidemiological study from the "Grupo de Hospitales Castrillo". J Perinat Med. 2002; 30: 149-157. (Pubitemid 34408064)
33. Neonatal meningitis. Epidemiological study of the Grupo de Hospitales Castrillo. An Esp Pediatr. 2002; 56: 556-563.
34. Wynn JL, Levy O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol. 2010; 37: 307-337.
35. Strunk T, Doherty D, Richmond P, Simmer K, Charles A, et al. Reduced levels of antimicrobial proteins and peptides in human cord blood plasma. Arch Dis Child Fetal Neonatal Ed. 2009; 94: F230-F231.
36. Strunk T, Currie A, Richmond P, Simmer K, Burgner D. Innate immunity in human newborn infants: prematurity means more than immaturity. J Matern Fetal Neonatal Med. 2011; 24(1): 25-31.
37. Hartel C, Osthues I, Rupp J, Haase B, Roder K, et al. Characterisation of the host inflammatory response to Staphylococcus epidermidis in neonatal whole blood. Arch Dis Child Fetal Neonatal Ed. 2008; 93: F140-F145. (Pubitemid 352038505)
38. Tatad AM, Nesin M, Peoples J, Cheung S, Lin H, et al. Cytokine expression in response to bacterial antigens in preterm and term infant cord blood monocytes. Neonatology. 2008; 94: 8-15. (Pubitemid 351896588)
39. Anderson P, Doyle LW. Neurobehavioral outcomes of schoolage children born extremely low birth weight or very preterm in the 1990s. JAMA. 2003; 289: 3264-3272. (Pubitemid 37430079)
40. Burguet A, Monnet E, Pauchard JY, Roth P, Fromentin C, et al. Some risk factors for cerebral palsy in very premature infants: Importance of premature rupture of membranes and monochorionic twin placentation. Biol Neonate. 1999; 75: 177-186. (Pubitemid 29067301)
41. Hamrick SE, Miller SP, Leonard C, Glidden DV, Goldstein R, et al. Trends in severe brain injury and neurodevelopmental outcome in premature newborn infants: the role of cystic periventricular leukomalacia. J Pediatr. 2004; 145: 593-599. (Pubitemid 39440935)
42. Rose SA, Feldman JF, Jankowski JJ. Recall memory in the first three years of life: a longitudinal study of preterm and term children. Dev Med Child Neurol. 2005; 47: 653-659. (Pubitemid 41447772)
43. Wolf MJ, Koldewijn K, Beelen A, Smit B, Hedlund R, et al. Neurobehavioral and developmental profile of very low birth-weight preterm infants in early infancy. Acta Paediatr. 2002; 91: 930-938. (Pubitemid 34876228)
44. Pickler R, Brown L, McGrath J, Lyon D, Rattican D, et al. Integrated reviewof cytokines in maternal, cord, and newborn blood: part II- associations with early infection and increased risk of neurologic damage in preterm infants. Biol Res Nurs. 2010; 11: 377-386.
45. Larroque B, Ancel PY, Marret S, Marchand L, Andre M, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): A longitudinal cohort study. Lancet. 2008; 371: 813-820. (Pubitemid 351330166)
46. Marlow N, Wolke D, Bracewell MA, Samara M. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005; 352: 9-19. (Pubitemid 40075676)
47. Volpe JJ. Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J Pediatr. 2008; 153: 160-163. (Pubitemid 351970579)
48. Schmitz T, Heep A, Groenendaal F, Huseman D, Kie S, et al. Interleukin-1beta, interleukin-18, and interferon-gamma expression in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus-markers of white matter damage? Pediatr Res. 2007; 61: 722-726. (Pubitemid 46804931)
49. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Hum Dev. 2004; 79: 1-15. (Pubitemid 39036744)
50. Leviton A, Dammann O. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res. 2004; 55: 541-545. (Pubitemid 38405836)
51. Mallard C, Welin AK, Peebles D, Hagberg H, Kjellmer I. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res. 2003; 28: 215-223. (Pubitemid 36207346)
52. Garnier Y, Berger R, Alm S, von Duering MU, Coumans AB, et al. Systemic endotoxin administration results in increased S100B protein blood levels and periventricular brain white matter injury in the preterm fetal sheep. Eur J Obstet Gynecol Reprod Biol. 2006; 124: 15-22. (Pubitemid 43020922)
53. Martin CR, Dammann O, Allred EN, Patel S, O'Shea TM, et al. Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia. J Pediatr. 2010; 157: 751-756 e751.
54. Mittendorf R, Covert R, Kohn J, Roizen N, Khoshnood B, et al. The association of coagulase-negative staphylococci isolated from the chorioamnion at delivery and subsequent development of cerebral palsy. J Perinatol. 2001; 21: 3-8. (Pubitemid 33710847)
55. Hagberg H, Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol. 2005; 18: 117-123. (Pubitemid 40477485)
56. Pachter JS, de Vries HE, Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol. 2003; 62: 593-604. (Pubitemid 36682632)
57. Stolp HB, Ek CJ, Johansson PA, Dziegielewska KM, Bethge N, et al. Factors involved in inflammation-induced developmental white matter damage. Neurosci Lett. 2009; 451: 232-236.
58. Stolp HB, Ek CJ, Johansson PA, Dziegielewska KM, Potter AM, et al. Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development. Eur J Neurosci. 2007; 26: 3465-3474. (Pubitemid 350243544)
59. Volpe JJ. Neurology Of The Newborn, 5e: Elsevier Science (medical). 2008; p. 1094.
60. Huang SH, Stins MF, Kim KS. Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes and infection/Institut Pasteur. 2000; 2: 1237-1244.
61. Girard S, Kadhim H, Roy M, Lavoie K, Brochu ME, et al. Role of perinatal inflammation in cerebral palsy. Pediatr Neurol. 2009; 40: 168-174.
62. Chau V, Brant R, Poskitt K, Tam E, Synnes A, et al. Postnatal infection is associated with widespread abnormalitites of brain development in premature newborns. Pediatric Research. 2012; 71(3): 274-279.
63. Marin ME, de la Rosa MC, Cornejo I. Enterotoxigenicity of Staphylococcus strains isolated from Spanish dry-cured hams. Appl Environ Microbiol. 1992; 58: 1067-1069.
64. Bautista L, Gaya P, Medina M, Nunez M. Aquantitative study of enterotoxin production by sheep milk staphylococci. Appl Environ Microbiol. 1988; 54: 566-569. (Pubitemid 18051145)
65. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med. 2007; 13: 1510-1514. (Pubitemid 350224240)
66. Mehlin C, Headley CM, Klebanoff SJ. An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J Exp Med. 1999; 189: 907-918.
67. Scheifele DW, Bjornson GL, Dyer RA, Dimmick JE. Deltalike toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis. Infect Immun. 1987; 55: 2268-2273. (Pubitemid 17139312)
68. Stevens NT, Sadovskaya I, Jabbouri S, Sattar T, O'Gara JP, et al. Staphylococcus epidermidis polysaccharide intercellular adhesin induces IL-8 expression in human astrocytes via a mechanism involving TLR2. Cell Microbiol. 2009; 11: 421-432.
69. Lambert PA, Worthington T, Tebbs SE, Elliott TS. Lipid S, a novel Staphylococcus epidermidis exocellular antigen with potential for the serodiagnosis of infections. FEMS Immunol Med Microbiol. 2000; 29: 195-202.
70. Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, et al. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med. 2009; 15: 641-648.
71. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem. 1999; 274: 17406-17409.
72. Schroder NW, Morath S, Alexander C, Hamann L, Hartung T, et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide- binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem. 2003; 278: 15587-15594. (Pubitemid 36799667)
73. Draing C, Sigel S, Deininger S, Traub S, Munke R, et al. Cytokine induction by Gram-positive bacteria. Immunobiology. 2008; 213: 285-296.
74. Natsuka M, Uehara A, Yang S, Echigo S, Takada H. A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-agonistic activities, resulting in synergistic activation of human monocytic cells. Innate Immun. 2008; 14: 298-308.
75. Queck SY, Khan BA, Wang R, Bach TH, Kretschmer D, et al. (2009) Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS pathogens. 5: e1000533.
76. Kocianova S, Vuong C, Yao Y, Voyich JM, Fischer ER, et al. Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J Clin Invest. 2005; 115: 688-694. (Pubitemid 40322243)
77. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 2004; 6: 269-275. (Pubitemid 38248010)
78. Du X, Fleiss B, Li H, D'Angelo B, SunY, et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS ONE. 2011; 6: e19583.
79. Stridh L, Smith PL, Naylor AS, Wang X, Mallard C. Regulation of Toll-like receptor 1 and -2 in neonatal mice brains after hypoxia-ischemia. J Neuroinflammation. 2011; 8: 45.
80. Ziegler G, Freyer D, Harhausen D, Khojasteh U, Nietfeld W, et al. Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal injury in experimental stroke. J Cereb Blood Flow Metab. 2011; 31: 757-766.
81. Mallard C, Wang X, Hagberg H. The role of Toll-like receptors in perinatal brain injury. Clin Perinatol. 2009; 36: 763-772, v-vi.
82. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev. 2007; 219: 88-102. (Pubitemid 47390004)
83. Strunk T, Richmond P, Simmer K, Currie A, Levy O, et al. Neonatal immune responses to coagulase-negative staphylococci. Curr Opin Infect Dis. 2007; 20: 370-375. (Pubitemid 47026233)
84. Stuyt RJ, Kim SH, Reznikov LL, Fantuzzi G, Novick D, et al. Regulation of Staphylococcus epidermidis-induced IFN-gamma in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF. Cytokine. 2003; 21: 65-73. (Pubitemid 36369392)
85. Wakabayashi G, Gelfand JA, Jung WK, Connolly RJ, Burke JF, et al. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J Clin Invest. 1991; 87: 1925-1935.
86. Strunk T, Prosser A, Levy O, Philbin V, Simmer K, et al. Human monocyte responsiveness to the commensal bacterium Staphylococcus epidermidis develops late in gestation. Pediatric Research. 2012; in press, doi:10.1038/pr.2012.48.
87. Strunk T, Richmond P, Prosser A, Simmer K, Levy O, et al. Method of bacterial killing differentially affects the human innate immune response to Staphylococcus epidermidis. Innate immunity. 2011; 17: 508-516.
88. Folkerth RD, Keefe RJ, Haynes RL, Trachtenberg FL, Volpe JJ, et al. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol. 2004; 14: 265-274. (Pubitemid 39095988)
89. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol. 1997; 177: 406-411. (Pubitemid 27385721)
90. Haynes RL, Baud O, Li J, Kinney HC, Volpe JJ, et al. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol. 2005; 15: 225-233. (Pubitemid 41161179)
91. Baerwald KD, Popko B. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. Journal of neuroscience research. 1998; 52: 230-239. (Pubitemid 28186167)
92. Pleyer U, Mondino BJ, Adamu SA, Pitchekian-Halabi H, Engstrom RE, et al. Immune response to Staphylococcus epidermidis-induced endophthalmitis in a rabbit model. Invest Ophthalmol Vis Sci. 1992; 33: 2650-2663.
93. Pourmand MR, Clarke SR, Schuman RF, Mond JJ, Foster SJ. Identification of antigenic components of Staphylococcus epidermidis expressed during human infection. Infect Immun. 2006; 74: 4644-4654. (Pubitemid 44157252)
94. Buzas K, Megyeri K, Miczak A, Fekete A, Degre M, et al. Different staphylococcal strains elicit different levels of production of T-helper 1-inducing cytokines. Acta Microbiol Immunol Hung. 2004; 51: 371-384. (Pubitemid 39531645)
95. Stout RD, Ferguson KP, Li YN, Lambe DW Jr. Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect Immun. 1992; 60: 922-927.
96. Peoples JD, Cheung S, Nesin M, Lin H, Tatad AM, et al. Neonatal cord blood subsets and cytokine response to bacterial antigens. Am J Perinatol. 2009; 26: 647-657.
97. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics. 2009; 124: e218-226.